Clinical studies for the prevention of postoperative delirium in oral cancer

Clinical studies for the prevention of postoperative delirium in oral cancer - Prevention of Oral Cancer Postoperative Delirium

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042066

Enrollment

1600

Registered

2020-10-09

Start date

2020-10-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral cancer,Delirium

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with oral cancer and underwent surgery under general anesthesia at our hospital between January 1, 2015, and December 31, 2022.

Exclusion criteria

Exclusion criteria: The presence or absence of post-operative delirium and related laboratory data and clinical findings are insufficient to be considered in the medical record.

Design outcomes

Primary

Measure	Time frame
After January 2015, the patient was diagnosed with oral cancer at the School of Dentistry Hospital and underwent surgery under general anesthesia. Patients who have been treated are eligible (approximately 200 cases per year, for a total of approximately 1600 cases). There will be no gender or age restrictions. The study will be conducted until December 31, 2022. For patients who develop postoperative delirium, the timing and duration of the onset of delirium will be studied, and the risk of delirium will be assessed. A comparison of the delirium-onset and delirium-free groups will be made to explore factors. The diagnosis of delirium will be made by a psychiatrist using the DSM-5 diagnostic criteria. The study will examine the presence or absence of postoperative delirium in the patients included in the study and the related tests Data and clinical findings will be used from the medical record. Background factors include age, gender, drinking history, smoking history, medication history, medical history, blood test results, surgical procedure, surgical Time, duration of anesthesia, blood loss, fever, insomnia, diarrhea, constipation, etc. will be considered.	—

Measure

Time frame

After January 2015, the patient was diagnosed with oral cancer at the School of Dentistry Hospital and underwent surgery under general anesthesia. Patients who have been treated are eligible (approximately 200 cases per year, for a total of approximately 1600 cases). There will be no gender or age restrictions. The study will be conducted until December 31, 2022. For patients who develop postoperative delirium, the timing and duration of the onset of delirium will be studied, and the risk of delirium will be assessed. A comparison of the delirium-onset and delirium-free groups will be made to explore factors. The diagnosis of delirium will be made by a psychiatrist using the DSM-5 diagnostic criteria. The study will examine the presence or absence of postoperative delirium in the patients included in the study and the related tests Data and clinical findings will be used from the medical record. Background factors include age, gender, drinking history, smoking history, medication history, medical history, blood test results, surgical procedure, surgical Time, duration of anesthesia, blood loss, fever, insomnia, diarrhea, constipation, etc. will be considered.

—

Countries

Japan

Contacts

Public ContactKabasawa Yuji

Tokyo Medical and Dental University Graduated school

kabasawa.ocsh@tmd.ac.jp03-5803-4647

Outcome results